Acesso livre
Acesso livre

Onco-hematologia

Estudo randomizado | Decitabina em baixa dose vs. azacitidina em baixa dose nas síndromes mielodisplásicas de baixo risco.

12 Ago, 2022 | 17:58h

Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS – NEJM Evidence

 

Comentário no Twitter

 


Estudo de braço único fase 2 | Seguimento de longo prazo da combinação entre antígeno de maturação de célula B e células T receptoras de antígeno quimérico CD19 no mieloma múltiplo.

10 Ago, 2022 | 14:12h

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: Durable Response Achieved With CAR-T Combination in Relapsed/Refractory Multiple Myeloma – Hematology Advisor

 

Comentário no Twitter

 


Diretriz | Manejo de tratamentos antitrombóticos em pacientes trombocitopênicos com câncer.

9 Ago, 2022 | 16:54h

EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer – HemaSphere

 


Estudo de braço único fase 1b | Venetoclax com gilteritinibe para leucemia mieloide aguda recorrente/refratária com mutação de FLT3.

2 Ago, 2022 | 12:52h

Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia – Journal of Clinical Oncology

 

Comentário no Twitter

 


Diretrizes de enfermagem da EBMT sobre a terapia CAR-T | Estrutura para o cuidado do paciente e tratamento das toxicidades comuns.

18 Jul, 2022 | 12:50h

The EBMT Immune Effector Cell Nursing Guidelines on CAR-T Therapy: A Framework for Patient Care and Managing Common Toxicities – Clinical Hematology International

 


Revisão | Doença cardiovascular em neoplasias mieloproliferativas.

18 Jul, 2022 | 12:45h

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review – JACC: CardioOncology

 


Estudo de braço único | Benefícios de longo prazo do tagraxofuspe para pacientes com neoplasia de célula dendrítica plasmocitoide blástica.

18 Jul, 2022 | 12:28h

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm – Journal of Clinical Oncology

Estudo relacionado: Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm – New England Journal of Medicine

 


Estudo randomizado | Dieta neutropênica vs. regular para quimioterapia de indução na leucemia aguda.

14 Jul, 2022 | 11:57h

Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trial – BMJ Supportive & Palliative Care (link para o resumo – $ para o texto completo)

Conteúdos relacionados:

Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline – Journal of Clinical Oncology

Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer – European Journal of Cancer (link para o resumo – $ para o texto completo)

Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis – BMJ Supportive & Palliative Care (link para o resumo – $ para o texto completo)

Things We Do For No Reason: Neutropenic Diet – Journal of Hospital Medicine (PDF)

 


Estudo randomizado | Zanubrutinibe vs. bendamustina e rituximabe na leucemia linfocítica crônica não tratada e no linfoma linfocítico de pequenas células.

12 Jul, 2022 | 11:14h

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial – The Lancet Oncology (link para o resumo – $ para o texto completo)

 


Recomendações clínicas para diagnóstico e monitoramento de pacientes com cardiomiopatia amiloide transtiretina.

11 Jul, 2022 | 13:53h

Clinical recommendations to diagnose and monitor patients with transthyretin amyloid cardiomyopathy in Asia – Clinical Cardiology

Conteúdos relacionados:

Characteristics and natural history of early-stage cardiac transthyretin amyloidosis – European Heart Journal

Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis – 2021 – Arquivos Brasileiros de Cardiologia

AHA Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis.

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases – European Heart Journal

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association – Circulation

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis – Canadian Journal of Cardiology

AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management – JACC: CardioOncology

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis – Circulation: Heart Failure

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.